Publications by authors named "Roy Rampling"

Claim this Profile
A
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.
Roy Rampling, Sharon Peoples, Paul J Mulholland, Allan James, Omar Al-Salihi

Clin Cancer Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for major depressive disorder in adults with glioma using the PHQ-9: a comparison of patient versus proxy reports.
Alasdair Grant Rooney, Shanne McNamara, Mairi Mackinnon, Mary Fraser, Roy Rampling

J Neurooncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma.
Alasdair Grant Rooney, Shanne McNamara, Mairi Mackinnon, Mary Fraser, Roy Rampling

Neuro Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments.
Alasdair G Rooney, Shanne McNamara, Mairi Mackinnon, Mary Fraser, Roy Rampling

Neuro Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.
Thierry Gorlia, Roger Stupp, Alba A Brandes, Roy R Rampling, Pierre Fumoleau

Eur J Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).
Roy Rampling, Marc Sanson, Thiery Gorlia, Denis Lacombe, Christina Lai

Neuro Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma.
Alasdair G Rooney, Shanne McNamara, Mairi Mackinnon, Mary Fraser, Roy Rampling

J Clin Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.
Michael Brada, Sally Stenning, Rhian Gabe, Lindsay C Thompson, David Levy, Roy Rampling

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.
Martin J van den Bent, Alba A Brandes, Roy Rampling, Mathilde C M Kouwenhoven, Johan M Kros

J Clin Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study.
Eric Raymond, Alba A Brandes, Christian Dittrich, Pierre Fumoleau, Bruno Coudert, Roy Rampling

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study.
Mark R Albertella, Paul M Loadman, Philip H Jones, Roger M Phillips, Roy Rampling

Clin Cancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma.
Mary F Dempsey, David Wyper, Jonathan Owens, Sally Pimlott, Vakis Papanastassiou, Roy Rampling

Nucl Med Commun· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of apolipoprotein E in glioblastoma: immunohistochemistry and clinical outcome.
James A R Nicoll, Elena Zunarelli, Roy Rampling, Lilian S Murray, Vakis Papanastassiou

Neuroreport· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis